Background: Management of older patients with medically refractory trigeminal neuralgia (TN) is yet a matter of debate. Objective: We sought to determine the benefit of stereotactic radiosurgery (SRS) as the sole surgical management in older patients (≥70 years). Methods: One hundred and twenty-seven patients (≥70 years) with typical TN underwent SRS as initial surgical management. The median maximum dose for the first procedure was 80 Gy. Repeat SRS was performed in 46 patients who developed recurrent pain. Results: After the first SRS, the initial pain control was achieved in 91% of patients. Complete pain relief (Barrow Neurological Institute [BNI] score I) developed in 75 patients (59%) and was maintained in 59, 39, and 22% of patients at 1, 3, and 5 years. Following repeat SRS, the rate of complete pain relief was 79, 55, and 41% at 1, 3, and 5 years. The chance of BNI I preservation was greater after repeat SRS compared to initial SRS (hazards ratio: 2.02, p < 0.0001). The incidence of trigeminal sensory loss was 17% after initial SRS but increased to 39% after repeat SRS. Conclusions: SRS alone was used effectively in older TN patients to achieve pain control. Recurrent pain responded to retreatment but was associated with an increased risk of sensory dysfunction.

Keywords:
Elderly, Trigeminal neuralgia, Radiosurgery
1.
Katusic S, Bergstralh E, Kurland LT: Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 1990;27:89-95.
2.
Gardner WJ: Concerning the mechanism of trigeminal neuralgia and hemifacial spasm. J Neurosurg 1962;19:947-958.
3.
Karam SD, Tai A, Wooster M, Rashid A, Chen R, Baig N, et al: Trigeminal neuralgia treatment outcomes following Gamma Knife radiosurgery with a minimum 3-year follow-up. J Radiat Oncol 2014;3:125-130.
4.
Oh IH, Choi SK, Park BJ, Kim TS, Rhee BA, Lim YJ: The treatment outcome of elderly patients with idiopathic trigeminal neuralgia: micro-vascular decompression versus gamma knife radiosurgery. J Korean Neurosurg Soc 2008;44:199-204.
5.
Burchiel KJ: A new classification for facial pain. Neurosurgery 2003;53:1164-1166.
6.
Harries AM, Mitchell RD: Percutaneous glycerol rhizotomy for trigeminal neuralgia: safety and efficacy of repeat procedures. Br J Neurosurg 2011;25:268-272.
7.
Kondziolka D, Lunsford LD, Flickinger JC, Young RF, Vermeulen S, Duma CM, et al: Stereotactic radiosurgery for trigeminal neuralgia: a multiinstitutional study using the gamma unit. J Neurosurg 1996;84:940-945.
8.
Maesawa S, Salame C, Flickinger JC, Pirris S, Kondziolka D, Lunsford LD: Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 2001;94:14-20.
9.
Pollock BE, Phuong LK, Gorman DA, Foote RL, Stafford SL: Stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 2002;97:347-353.
10.
Sekula RF Jr, Frederickson AM, Jannetta PJ, Quigley MR, Aziz KM, Arnone GD: Microvascular decompression for elderly patients with trigeminal neuralgia: a prospective study and systematic review with meta-analysis. J Neurosurg 2011;114:172-179.
11.
Sekula RF, Marchan EM, Fletcher LH, Casey KF, Jannetta PJ: Microvascular decompression for trigeminal neuralgia in elderly patients. J Neurosurg 2008;108:689-691.
12.
Barker FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD: The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 1996;334:1077-1084.
13.
Henson CF, Goldman HW, Rosenwasser RH, Downes MB, Bednarz G, Pequignot EC, et al: Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution. Int J Radiat Oncol Biol Phys 2005;63:82-90.
14.
Jho HD, Lunsford LD: Percutaneous retrogasserian glycerol rhizotomy. Current technique and results. Neurosurg Clin N Am 1997;8:63-74.
15.
Lunsford LD: Treatment of tic douloureux by percutaneous retrogasserian glycerol injection. JAMA 1982;248:449-453.
16.
Taha JM, Tew JM Jr, Buncher CR: A prospective 15-year follow up of 154 consecutive patients with trigeminal neuralgia treated by percutaneous stereotactic radiofrequency thermal rhizotomy. J Neurosurg 1995;83:989-993.
17.
Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al: AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008;15:1013-1028.
18.
Kanpolat Y, Savas A, Bekar A, Berk C: Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery 2001;48:524-532.
19.
Hasegawa T, Kondziolka D, Spiro R, Flickinger JC, Lunsford LD: Repeat radiosurgery for refractory trigeminal neuralgia. Neurosurgery 2002;50:494-500.
20.
Park KJ, Kondziolka D, Berkowitz O, Kano H, Novotny J Jr, Niranjan A, Flickinger JC, Lunsford LD: Repeat gamma knife radiosurgery for trigeminal neuralgia. Neurosurgery 2012;70:295-305.
21.
Tempel ZJ, Chivukula S, Monaco EA 3rd, Bowden G, Kano H, Niranjan A, Chang EF, Sneed PK, Kaufmann AM, Sheehan J, Mathieu D, Lunsford LD: The results of a third Gamma Knife procedure for recurrent trigeminal neuralgia. J Neurosurg 2015;122:169-179.
22.
Tuleasca C, Carron R, Resseguier N, Donnet A, Roussel P, Gaudart J, Levivier M, Regis J: Repeat Gamma Knife surgery for recurrent trigeminal neuralgia: long-term outcomes and systematic review. J Neurosurg 2014;121(suppl 2):210-221.
23.
Régis J, Tuleasca C, Resseguier N, Carron R, Donnet A, Yomo S: The very long-term outcome of radiosurgery for classical trigeminal neuralgia. Stereotact Funct Neurosurg 2016;94:24-32.
24.
Smith ZA, De Salles AA, Frighetto L, Goss B, Lee SP, Selch M, Wallace RE, Cabatan-Awang C, Solberg T: Dedicated linear accelerator radiosurgery for the treatment of trigeminal neuralgia. J Neurosurg 2003;99:511-516.
25.
Villavicencio AT, Lim M, Burneikiene S, Romanelli P, Adler JR, McNeely L, Chang SD, Fariselli L, McIntyre M, Bower R, Broggi G, Thramann JJ: Cyberknife radiosurgery for trigeminal neuralgia treatment: a preliminary multicenter experience. Neurosurgery 2008;62:647-654.
26.
Kondziolka D, Lunsford LD, Flickinger JC, Young RF, Vermeulen S, Duma CM, et al: Stereotactic radiosurgery for trigeminal neuralgia: a multiinstitutional study using the gamma unit. J Neurosurg 1996;84:940-945.
27.
Mousavi SH, Niranjan A, Huang MJ, Laghari FJ, Shin SS, Mindlin JL, Flickinger JC, Lunsford LD: Early radiosurgery provides superior pain relief for trigeminal neuralgia patients. Neurology 2015;85:2159-2165.
28.
Rogers CL, Shetter AG, Fiedler JA, Smith KA, Han PP, Speiser BL: Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of the Barrow Neurological Institute. Int J Radiat Oncol Biol Phys 2000;47:1013-1019.
29.
Gellner V, Kurschel S, Kreil W, Holl EM, Ofner-Kopeinig P, Unger F: Recurrent trigeminal neuralgia: long term outcome of repeat gamma knife radiosurgery. J Neurol Neurosurg Psychiatry 2008;79:1405-1407.
30.
Pollock BE: Surgical management of medically refractory trigeminal neuralgia. Curr Neurol Neurosci Rep 2011;12:125-131.
31.
Pollock BE, Foote RL, Stafford SL, Link MJ, Gorman DA, Schomberg PJ: Results of repeated gamma knife radiosurgery for medically unresponsive trigeminal neuralgia. J Neurosurg 2000;93:162-164.
32.
Aubuchon AC, Chan MD, Lovato JF, Balamucki CJ, Ellis TL, Tatter SB, et al: Repeat gamma knife radiosurgery for trigeminal neuralgia. Int J Radiat Oncol Biol Phys 2011;81:1059-1065.
33.
Huang CF, Chuang JC, Tu HT, Lin LY: Repeated Gamma Knife surgery for refractory trigeminal neuralgia. J Neurosurg 2006;105:99-102.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.